Granules India
₹814
- Market Cap
- ₹22,422Cr.
- P/E Ratio
- 34.5
- P/B Ratio
- 3.97
- EPS (TTM)
- ₹23.59
- Div Yield
- 0.21%
- ROCE
- 15.5%
- ROE
- 13.8%
52W Low: ₹53052W High: ₹924
Themes:💊 Pharma & CDMO
Descriptive screens built from published data — not investment advice.
At a glance
- Sales have grown 6.0% a year over three years.
- Debt is 0.30× its shareholders’ equity.
From reported financials and exchange prices. Descriptive only, not advice.
Granules_India — Price
Interval
Style
Failed: 503
Evenstocks Score
Middle third
Overall
Valuation
Quality
Fundamental
Growth
Investment Checklist
Quick assessment based on key parametersPerformance
N/ATrailing return unavailableValuation
P/E 34.5P/E: 34.5 | P/B: 3.97Growth
ModestSales CAGR — 3Y: 6% · 1Y: 25%Profitability
ModerateROCE: 15.5% | ROE: 13.8%Key Metrics
Valuation
PEG Ratio 6.90
Price / Sales 3.98x
Price / FCF 93.8x
Book Value ₹205
Margins & returns
Operating Margin 23%
Net Margin 11.8%
Return on Assets 8.6%